Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Gains from Investment Securities (2017 - 2025)

HealthLynked (HLYK) has disclosed Gains from Investment Securities for 9 consecutive years, with $75000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities rose 4377.61% to $75000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $75000.0, a 51.35% increase, with the full-year FY2024 number at $61579.0, up 20.89% from a year prior.
  • Gains from Investment Securities was $75000.0 for Q3 2025 at HealthLynked, down from $6.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $9.1 million in Q1 2024 to a low of $1675.0 in Q3 2024.
  • A 5-year average of $2.9 million and a median of $1.0 million in 2021 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: surged 144821.81% in 2022, then tumbled 99.96% in 2024.
  • HealthLynked's Gains from Investment Securities stood at $3604.0 in 2021, then soared by 144821.81% to $5.2 million in 2022, then plummeted by 99.02% to $50937.0 in 2023, then rose by 20.89% to $61579.0 in 2024, then increased by 21.79% to $75000.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Gains from Investment Securities are $75000.0 (Q3 2025), $6.1 million (Q2 2025), and $6.2 million (Q1 2025).